One Income Statement for the Biopharma Ecosystem

The profitability of the drug industry cannot be judged by measuring its larger and more successful companies and ignoring unknown or struggling competitors. We’re compiling an integrated income statement for the drug industry to determine its overall profitability. So far, our analysis shows that the whole industry is only moderately profitable and that top-down price controls would cut deeply into R&D.